Gastrointestinal Inflammations and Gut Microbiota

Dr. Neeraj Mishra has been serving as a Professor at the Amity Institute of Pharmacy, Gwalior, since July 2019. He brings approximately 20 years of experience in teaching and research. Dr. Mishra has published over 100 papers of international and national significance, focusing on novel drug delivery systems, oral delivery of synbiotics, localized drug delivery, and targeted and controlled drug delivery using nanocarriers and microparticles for treating breast and colon cancer, as well as neurodegenerative disorders. He has also edited more than 15 books and authored 25 book chapters. He is the recipient of the “Distinguished Professor Award” (2019) from DST-NSTMIS, SPAICS, Indore, Madhya Pradesh, and the “Outstanding Scientist Award” (2020) from the 6th International Scientist Awards on Engineering, Science, and Medicine, held in Chennai, India. Further, Dr. Mishra received the “Distinguished Professor Award” in 2021 from the Indian Pharmaceutical Association, MP State Branch, Indore, and the “Best Academician Award” at the Indian Pharmacy Graduate Association’s M.P. State International Conference, held on May 6, 2023, at the DAVV Auditorium, Indore, India.Dr. Sumel Ashique has been working as an Assistant Professor at Bengal College of Pharmaceutical Sciences & Research, Durgapur 713212, West Bengal, India. He has 4 years of teaching experience. He has achieved 80 publications in International and national accredited reputed journals. He has knowledge in drug delivery, nanotechnology and targeted treatment strategy. He is working as potential reviewer for many well-known publishers (Elsevier, Springer, Dove Press, and Bentham Sc.). He has also five granted patents from IP and Australia, 20 published book chapters in Bentham, Springer, Elsevier, Bentham and Taylor & Francis. Currently is editing 14 books under CRC Press, Elsevier, Taylor and Francis, Wiley, Nova Science and Springer. He has published 80+ papers including research, reviews, column articles, editorials in Scopus, and WOS indexed. He is serving as guest editor in JoVE journal (IF 1.2, Scopus & WOS indexed), Current Probiotics (Bentham Science) & Current Indian Science Journal. He is a potential reviewer for Elsevier, Springer, Taylor & Francis and Wiley journals for expertise in the field of targeted drug delivery, nanotechnology, gut-microbiome and postbiotics. Current he is pursuing his PhD degree from Lovely Professional University, Punjab, India (NAAC A++) in the Pharmaceutical Science department.Dr. Anoop Kumar is currently serving as an Assistant Professor in the Department of Pharmacology and Clinical Research at Delhi Pharmaceutical Sciences & Research University (DPSRU), New Delhi, India. Previously, he held the position of Assistant Professor in the Department of Pharmacology and Toxicology at the National Institute of Pharmaceutical Education and Research (NIPER), Raebareli. He has also served as an Associate Professor and Officiating Head in the Department of Pharmacology at ISF College of Pharmacy, Moga, Punjab. Additionally, Dr. Kumar has worked as a research scientist in the Medical Affairs and Clinical Research Department at Sun Pharmaceutical Limited, Gurugram, and at the Translational Health Science and Technology Institute (THSTI), Faridabad, India. Dr. Kumar has authored over 80 research and review articles and 15 book chapters in internationally renowned journals. He is also the author of three books. He has received research grants from the Indian government. His research interests include drug repurposing using computational, in vitro, and in vivo techniques, meta-analysis, signal analysis in pharmacovigilance, and pharmacoeconomic studies.

• Chapter 1 Introduction to Gastrointestinal Inflammation and Gut MicrobiotaChapter 2Pathophysiology and Risk Factors Associated with Gastrointestinal InflammationChapter 3Diagnosis, Screening, and Prevention Techniques of Gastrointestinal InflammationsChapter 4Influence of Gut-Brain Axis on Gastrointestinal Health and BenefitsChapter 5Interplay Between SCFAs, ROS, SODs, and Gastrointestinal Inflammations Chapter 6Role of Probiotic, Prebiotic and Postbiotics in Management of Gastrointestinal InflammationsChapter 7Role of Genetic Factor in Gastrointestinal inflammationChapter 8Interaction of Antibiotics with Gut Microbiota and its Implications for Treating Gastrointestinal InflammationsChapter 9Role of the Immune System in Gastrointestinal InflammationChapter 10Advancements in Diagnostic Techniques and Technology for GastroenterologyChapter 11Gut Microbiota Based Strategies for the Management of Gastrointestinal InflammationsChapter 12Nanoparticles-Based Approaches for the Management of Gastrointestinal InflammationsChapter 13 Experimental Animal Models and In-Vitro Models for Gastrointestinal InflammationChapter 14The Neuroinflammation Enigma: Cracking the Code of the Gut-Brain ConnectionChapter 15Functional Foods and Nanocarriers for the Management of Gastrointestinal InflammationsChapter 16Polysaccharide-Based Nanoparticles for the Management of Gastrointestinal InflammationsChapter 17Lipid Nanocarriers for the Treatment of Gastrointestinal InflammationsChapter 18Exosomes Mediated Nanocarriers for Gastrointestinal Inflammation ManagementChapter 19Plant-Based Bio-Actives Encapsulated Nanocarriers for Gastrointestinal Inflammations ManagementChapter 20Future Prospects and Clinical Studies for the Treatment of Gastrointestinal Inflammations